Literature DB >> 18374763

Clinicopathologic factors influencing postoperative prognosis in patients with small-sized adenocarcinoma of the lung.

Masayoshi Inoue1, Tetsuya Takakuwa, Masato Minami, Hiroyuki Shiono, Tomoki Utsumi, Yoshihisa Kadota, Takuma Nasu, Katsuyuki Aozasa, Meinoshin Okumura.   

Abstract

OBJECTIVE: Recent technologic developments in computed tomography have increased the incidence of surgical intervention for small-sized lung cancer. Although indications of a sublobar resection for early disease have been discussed, we occasionally encounter locally advanced small-sized lung cancer with node metastasis. The present study aimed to clarify the histopathologic factors influencing nodal involvement and prognosis of such patients.
METHODS: We studied 97 patients who underwent complete resection for an adenocarcinoma of 2 cm or less in diameter. Lymph node metastasis and necrosis were microscopically evaluated, whereas immunohistochemical studies were also performed with Ki-67 and D2-40 for proliferation activity and lymphatic invasion, respectively. In addition, carcinoembryonic antigen expression in the tumor and its level in serum were investigated. Survival analysis was then conducted by using these clinicopathologic factors.
RESULTS: The 5-year disease-free survival rate was 90%. Nodal involvement was significantly frequent in patients with tumors showing microscopic necrosis, a Ki-67 labeling index of greater than 5%, and an increased serum carcinoembryonic antigen level. Furthermore, 5-year disease-free survival was worse in patients with lesions showing microscopic necrosis (68%), a Ki-67 labeling index of greater than 5% (76%), and lymphatic invasion detected with D2-40 staining (77%). Multivariate analysis identified lymphatic invasion detected with D2-40 to be an independent predictor for postoperative recurrence.
CONCLUSIONS: These results indicate that microscopic necrosis, Ki-67 labeling index, and serum carcinoembryonic antigen level are predictors of nodal involvement. Careful postoperative follow-up examinations for recurrence are required for patients with tumors that show microscopic necrosis, high Ki-67 labeling index, and lymphatic invasion, even in those with stage IA disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18374763     DOI: 10.1016/j.jtcvs.2007.10.034

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  12 in total

1.  An automated segmentation approach for highlighting the histological complexity of human lung cancer.

Authors:  J C Sieren; J Weydert; A Bell; B De Young; A R Smith; J Thiesse; E Namati; Geoffrey McLennan
Journal:  Ann Biomed Eng       Date:  2010-06-23       Impact factor: 3.934

2.  Positive correlation between sarcopenia and elevation of neutrophil/lymphocyte ratio in pathological stage IIIA (N2-positive) non-small cell lung cancer patients.

Authors:  Takuma Tsukioka; Nobuhiro Izumi; Shinjiro Mizuguchi; Chung Kyukwang; Hiroaki Komatsu; Michihito Toda; Kantaro Hara; Hikaru Miyamoto; Noritoshi Nishiyama
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-08-13

3.  Using optical spectroscopy to longitudinally monitor physiological changes within solid tumors.

Authors:  Karthik Vishwanath; Hong Yuan; William T Barry; Mark W Dewhirst; Nimmi Ramanujam
Journal:  Neoplasia       Date:  2009-09       Impact factor: 5.715

4.  Pre-treatment CT imaging in stage IIIA lung cancer: Can we predict local recurrence after definitive chemoradiotherapy?

Authors:  Andrew J Plodkowski; Jose Arimateia Batista Araujo-Filho; Cameron D A Simmers; Jeffrey Girshman; Micheal Raj; Junting Zheng; Andreas Rimner; Michelle S Ginsberg
Journal:  Clin Imaging       Date:  2020-07-17       Impact factor: 1.605

Review 5.  Small peripheral lung adenocarcinoma: CT and histopathologic characteristics and prognostic implications.

Authors:  Zhi-gang Chu; Zhi-gang Yang; Heng Shao; Zhi-yu Zhu; Wen Deng; Shi-si Tang; Jing Chen; Yuan Li
Journal:  Cancer Imaging       Date:  2011-12-28       Impact factor: 3.909

Review 6.  Necrosis and apoptotic index as prognostic factors in non-small cell lung carcinoma: a review.

Authors:  Charalampos Gkogkou; Konstantina Frangia; Muhammad W Saif; Rodoula Trigidou; Konstantinos Syrigos
Journal:  Springerplus       Date:  2014-03-01

7.  Ki-67 is a strong prognostic marker of non-small cell lung cancer when tissue heterogeneity is considered.

Authors:  Kazuhiro Tabata; Tomonori Tanaka; Tomayoshi Hayashi; Takashi Hori; Sayuri Nunomura; Suguru Yonezawa; Junya Fukuoka
Journal:  BMC Clin Pathol       Date:  2014-05-13

8.  Sialyl Lewis X as a predictor of skip N2 metastasis in clinical stage IA non-small cell lung cancer.

Authors:  Hiroaki Komatsu; Shinjiro Mizuguchi; Nobuhiro Izumi; Kyukwang Chung; Shoji Hanada; Hidetoshi Inoue; Shigefumi Suehiro; Noritoshi Nishiyama
Journal:  World J Surg Oncol       Date:  2013-12-06       Impact factor: 2.754

9.  Computed tomography morphologic features of pulmonary adenocarcinoma with brain/bone metastasis.

Authors:  Ki-Eun Hwang; Su-Jin Oh; Chul Park; Se-Jeong Jeon; Jeong-Mi Lee; Byong-Ki Cha; Kwon-Ha Yoon; Eun-Taik Jeong; Hak-Ryul Kim
Journal:  Korean J Intern Med       Date:  2016-02-15       Impact factor: 2.884

10.  Loss of Muscle Mass is a Novel Predictor of Postoperative Early Recurrence in N2-Positive Non-Small-Cell Lung Cancer.

Authors:  Takuma Tsukioka; Nobuhiro Izumi; Chung Kyukwang; Hiroaki Komatsu; Michihito Toda; Kantaro Hara; Noritoshi Nishiyama
Journal:  Ann Thorac Cardiovasc Surg       Date:  2018-02-16       Impact factor: 1.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.